Member Exclusive

Perspective: the benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions

This perspective, brought to MedChemNet members by Future Medicinal Chemistry, discusses the development of in silico approaches and methods to utilize big data in small molecule development.

0
0

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.